MAZZONI, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 69
NA - Nord America 64
EU - Europa 29
SA - Sud America 17
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 187
Nazione #
US - Stati Uniti d'America 64
SG - Singapore 32
VN - Vietnam 14
BR - Brasile 10
CN - Cina 8
IE - Irlanda 6
IT - Italia 6
SE - Svezia 5
AR - Argentina 3
GB - Regno Unito 3
HK - Hong Kong 3
IN - India 3
AO - Angola 2
JP - Giappone 2
NL - Olanda 2
PL - Polonia 2
RU - Federazione Russa 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZA - Sudafrica 2
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
DE - Germania 1
EC - Ecuador 1
FI - Finlandia 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
KZ - Kazakistan 1
PE - Perù 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TR - Turchia 1
Totale 187
Città #
Singapore 15
Ashburn 10
Dublin 6
Ho Chi Minh City 5
Milan 5
Chandler 4
Los Angeles 4
New York 4
Boardman 3
Hanoi 3
Hong Kong 3
Poplar 3
Beijing 2
Dallas 2
Gjilan 2
Haiphong 2
Hefei 2
Luanda 2
Orem 2
Santa Clara 2
São Paulo 2
Thái Nguyên 2
Tokyo 2
Tunis 2
Warsaw 2
Amsterdam 1
Ankara 1
Arequipa 1
Astolfo Dutra 1
Belo Horizonte 1
Bhopal 1
Boston 1
Bremen 1
Brooklyn 1
Buffalo 1
Bắc Ninh 1
Cape Town 1
Chennai 1
Columbus 1
Concordia 1
Council Bluffs 1
Curitiba 1
Damascus 1
Fernando de la Mora 1
Fremont 1
Helsinki 1
Jakarta 1
Johannesburg 1
Juazeiro do Norte 1
Jundiaí 1
Kansas City 1
Krasnodar 1
Luján 1
Manassas 1
Minneapolis 1
Moscow 1
Oklahoma City 1
Parma 1
Phoenix 1
Princeton 1
Pune 1
Quito 1
Rio de Janeiro 1
San Isidro 1
Santiago 1
Seattle 1
Shymkent 1
Sumaré 1
Tehran 1
The Dalles 1
Torres 1
Vĩnh Tường 1
Totale 138
Nome #
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy 73
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04–2016 31
A prospective study on clinicians’ attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020) 31
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 31
Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study 27
Totale 193
Categoria #
all - tutte 594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 1 0 0 2 1 1 0 1 1
2022/202321 2 1 1 1 2 2 0 1 8 0 2 1
2023/20244 1 0 0 0 1 1 0 0 0 0 0 1
2024/202518 0 2 0 1 2 3 1 2 0 2 1 4
2025/2026143 2 3 24 41 64 9 0 0 0 0 0 0
Totale 193